CRL vs MIRM · rev $2.00B vs rev $336.1M
Charles River Laboratories (CRL) versus Mirum Pharmaceuticals Inc (MIRM) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported MIRM revenue for 2026-06-30 was $336.1M. Net income was -$857.4M. MIRM currently screens at market cap $6.22B.
CRL currently screens at market cap $7.78B. MIRM currently screens at market cap $6.22B.
Not investment advice. Open the CRL and MIRM stock pages for the full models.
Not investment advice.